E.S.PKU - European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria

FacebookXLinkedInYouTubeInstagram
E.S.PKU Menu
  • News
    • Shades of PKU – Why and how our storytelling can bring about a change28th June 2025
    • E.S.PKU launches PKU Life Stories Campaign27th January 2025
    • UNMET MEDICAL NEED IN PHENYLKETONURIA (PKU)27th November 2024
    • View all news
    • Close
  • Conference
      • Conferences
        • General Information
          • Conference Newsletter
          • Conference Feedback
        • E.S.PKU Conference 2025
          • Registration
        • Close
      • Conference History
        • E.S.PKU Conference History
          • E.S.PKU Conference 2024
          • E.S.PKU Conference 2023
          • E.S.PKU Conference 2022
          • E.S.PKU Conference 2021
        • Close
    • Close
  • Who We Are?
      • The Organization
        • Who We Are?
          • For Delegates
          • Documentations
          • Videos
          • Annual Reports
          • Weblinks
        • Close
      • What We Do
        • Projects
          • Benchmark Report
          • Consensus Paper
          • European Guidelines
          • Advocacy Toolkit
          • E.S.PKU Metabolic Passport
          • PKU Day
        • Close
      • Sheila Jones Award
        • Sheila Jones Award
          • Sheila Jones Award – Submission
        • Close
    • Close
  • Cross Party Alliance
    • Cross Party Alliance
    • Supporters
    • Policy Areas
      • Revision of the EU Orphan Drug Regulation
      • EU Action Plan on Rare Diseases
      • Close
    • Library
    • Close
    • Close
Home Treatment for adult metabolic patients is insufficient ESPKU-Statement-on-Transition-and-Adult-Care

ESPKU-Statement-on-Transition-and-Adult-Care

gregor.hammerschmidt 5th November 2019

ESPKU-Statement-on-Transition-and-Adult-Care

  • Imprint
  • Manage Subscriptions
  • Contact